269 related articles for article (PubMed ID: 31404528)
21. Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.
Wang J; Zhang H; Kaul A; Li K; Priyandoko D; Kaul SC; Wadhwa R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680087
[No Abstract] [Full Text] [Related]
22. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
24. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
25. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
26. Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies.
Shah HS; Nasrullah U; Zaib S; Usman F; Khan A; Gohar UF; Uddin J; Khan I; Al-Harrasi A
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834081
[TBL] [Abstract][Full Text] [Related]
27. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
29. Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.
Lim DW; Kim JG; Lim EY; Kim YT
Inflammopharmacology; 2018 Feb; 26(1):207-215. PubMed ID: 28849547
[TBL] [Abstract][Full Text] [Related]
30. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
Atteeq M
Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
32. Molecular insight in the multifunctional activities of Withaferin A.
Vanden Berghe W; Sabbe L; Kaileh M; Haegeman G; Heyninck K
Biochem Pharmacol; 2012 Nov; 84(10):1282-91. PubMed ID: 22981382
[TBL] [Abstract][Full Text] [Related]
33. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
34. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
35. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
Xia S; Miao Y; Liu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656
[TBL] [Abstract][Full Text] [Related]
36. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing.
Joshi VK; Joshi A
J Ethnopharmacol; 2021 Aug; 276():114101. PubMed ID: 33831467
[TBL] [Abstract][Full Text] [Related]
37. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
38. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
39. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
40. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]